Prot# SHP621-302: A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) with E

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/16 → 12/1/21

Funding

  • PPD Development (Prot# SHP621-302)
  • Shire Human Genetic Therapies, Inc. (Prot# SHP621-302)